Company Alder BioPharmaceuticals, Inc.
Equities
US0143391052
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | 54 | - | |
Roger K. Cady
PRN | Corporate Officer/Principal | - | 16-06-05 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 18-04-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 83,637,234 | 73,871,285 ( 88.32 %) | 0 | 88.32 % |
Company contact information
Lundbeck Seattle BioPharmaceuticals, Inc.
11804 North Creek Parkway South
98011, Bothell
+425 205 2900
http://www.alderbio.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |